{"id":76844,"date":"2024-10-16T03:00:11","date_gmt":"2024-10-16T03:00:11","guid":{"rendered":"http:\/\/ef0c618e67e79a3c7b3e5726b0a979d5"},"modified":"2024-10-16T03:00:11","modified_gmt":"2024-10-16T03:00:11","slug":"experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say","status":"publish","type":"post","link":"https:\/\/wp.timesamerica.net\/experimental-als-drug-could-offer-new-hope-for-patients-if-approved-researchers-say\/","title":{"rendered":"Experimental ALS drug could offer new hope for patients if approved, researchers say"},"content":{"rendered":"\n
New hope could be on the horizon for ALS patients<\/span> in the form of a “breakthrough” drug, researchers say.<\/p>\n Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative diseases, is seeking approval for a new medication<\/span> for ALS (amyotrophic lateral sclerosis).<\/p>\n ALS is a progressive neurodegenerative disease that gradually impairs muscle function, eventually robbing the patient of the ability to walk, talk, eat and even breathe, per the ALS Association.<\/p>\n MOM WITH ALS SHARES MOTHER-SON WEDDING DANCE IN FLORIDA<\/u><\/strong><\/span><\/p>\n This month, Neuvivo submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for NP001 (sodium chlorite infusion).<\/p>\n